The Investor Relations website contains information about Osiris Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
http://investor.osiris.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.5 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
48
SITE IP
23.213.123.49
LOAD TIME
0.503 sec
SCORE
6.2
Investor Relations | Osiris Therapeutics, Inc. | investor.osiris.com Reviews
https://investor.osiris.com
The Investor Relations website contains information about Osiris Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
investor.osiris.com
Osiris Therapeutics Announces Second Quarter 2015 Financial Results (NASDAQ:OSIR)
http://investor.osiris.com/releasedetail.cfm?ReleaseID=925853
File is in Briefcase. Osiris Therapeutics Announces Second Quarter 2015 Financial Results. Osiris Therapeutics, Inc. NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today its financial results for the second quarter of 2015. Second Quarter Highlights and Developments. Increased product revenue for the quarter to. Increased coverage for Grafix. Per share and with.
Osiris Therapeutics, Inc. Press Releases
http://investor.osiris.com/releases.cfm
Osiris Provides Update Regarding NASDAQ Listing Matters. COLUMBIA, Md., Aug. 17, 2016 (GLOBE NEWSWIRE) - Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the "Company") today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market ("NASDAQ"). As previously disclosed, on each of March 17, 2016 and May 12, 2016 the Company received a notification from NAS. File is in Briefcase. File is in Briefcase. Osiris Provides Update Regarding NASDAQ Listing Matters. 10 Clin...
Osiris Therapeutics, Inc. RSS News Feeds
http://investor.osiris.com/rss.cfm
Really Simple Syndication (RSS) is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates. How do I use RSS? To make use of RSS, you'll need an RSS reader, or aggregator. An RSS aggregator can be a stand-alone application, or a plug-in for another program you already use, such as Microsoft Outlook. Some web browsers, such as Firefox. To view a feed in your RSS Aggregator:.
Osiris Therapeutics, Inc. Investment Calculator
http://investor.osiris.com/calculator.cfm
Calculate Current Value and Shares Since: August 8, 2006. There are no adjustments for your investment. 2016 Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. Shareholder Briefcase
http://investor.osiris.com/briefcase.cfm
Collect, zip and download files from our Investor Relations website. Click on the briefcase icon. Located near most downloadable files throughout our IR website and use this page to manage your briefcase. You currently have no files in your Shareholder Briefcase. 2016 Osiris Therapeutics, Inc.
TOTAL PAGES IN THIS WEBSITE
20
Investor Relations | Orion Energy Systems
Skip to main navigation. We are a U.S. manufacturer of high quality, industry leading LED lighting products focused on changing the way customers think about a lighting company. We provide competitively priced products with the highest quality, highest efficiency and industry leading customer service. From the very first handshake to the after-sale support, our ingenuity and dedication are the difference we bring to every opportunity. Mar 29, 2018 11:48 PM EDT. March 14, 2018 at 8:00 AM EDT. Product Term...
Shareholder structure | Orion Investment S.A. Developer Kraków
General meetings of shareholders. The Capital Group ORION INVESTMENT S.A. (Public Limited Company) consists of the following entities:. ORION INVESTMENT S.A. (Public Limited Company) - the parent company,. Inf Orion Inwestycje sp. z o.o. (Limited Liability Company) S.K.A. - a subsidiary,. Inf Orion Inwestycje sp. z o.o. (Limited Liability Company) - a subsidiary,. Inf Orion Inwestycje sp. z o.o. (Limited Liability Company) BIS S.K.A. - a subsidiary,. The Board of Orion Investment S.A. Since 2004 he has b...
IRWeblink
Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.
Ormat Technologies Inc. | Corporate Profile
Join our Q2 2015 earnings call on Aug 4 at 9 AM EDT. Q2 2015 Earnings Call. As of August 7, 2015 -. Minimum 20 minute delay. In addition to owning and operating geothermal power plants in the United States and other countries, the Company designs, manufactures and sells power generating equipment as well as complete power plants on a turnkey basis. Ormat currently has operations in the United States, Guatemala and Kenya. Ormat Technologies Reports 2015 Second Quarter Results. Ormat Technologies, Inc....
investor.oshkoshcorporation.com
Oshkosh Corporation - Investors - Overview
Mar 29, 2018 04:02 PM. Pricing delayed 20 minutes. Annual and Quarterly Reports. Oshkosh Corporation Tax Strategy. Annual and Quarterly Reports. Oshkosh Corporation Tax Strategy. Enter the code shown above. Unsubscribe from email alerts. Oshkosh, WI 54903-2566. Oshkosh Corporation - A Different Integrated Global Industrial. Oshkosh Corporation - A Different Integrated Global Industrial. Oshkosh Corporation - A Different Integrated Global Industrial. Annual and Quarterly Reports. 2017 Annual Report (PDF 2...
Investor Relations | Osiris Therapeutics, Inc.
Skip to main navigation. Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO. Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation. 03/22/16 10:00 AM EDT. Alliance Regenerative for Medicine - 4th Annual Cell and Gene Investor Day. News and Events submenu. Financials and Filings submenu. 03/29/18 11:49 pm EDT. Stock Information sub menu. Check Our FAQs and if you still have questions please contact us. Osiris Therapeutics, Inc.
Owens Corning - Investors - Overview
Skip to main content. Total Protection Roofing System. Find an Insulation Professional. Learn how to Install. Commercial and Institutional Insulation. Commercial Insulation Product List. Architectural and Engineering Information Center. Find a Sales Representative. Consumer Goods, Electrical and Electronics. Interns and New Grads. As we enter 2018, we are well positioned to deliver strong results and build value for our company. Mike Thaman - Chairman and Chief Executive Officer. March 29, 2018. Leader, ...
Investor Relations | Oxford Industries Inc.
Skip to main navigation. SEC and Financial Information. SEC and Financial Information. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Oxford Industries, Inc.'s financial performance into perspective. Oxford Reports Fourth Quarter and Full Fiscal Year 2017 Results. Oxford to Release Fourth Quarter and Fiscal 2017 Results on March 28, 2018. Mar 28,2018 4:30 PM.
Investors & Media | Oxigene
Efficiently Creating Value with Innovative Science. Day High: 1.35. Day Low: 1.27. Aug 7, 2015. Delayed 20 min., by eSignal. OXiGENE is highly committed to delivering value to its shareholders. Were working to translate innovative science into important, next-generation therapeutic products that deliver significant medical benefits to patients suffering from cancer. Our pipeline currently includes fosbretabulin and other preclinical and clinical stage therapeutic candidates. Aug 4, 2015. Jul 28, 2015.
investor.pacificbiosciences.com
INVESTOR RELATIONS | Pacific Biosciences of California
Skip to main navigation. ANNUAL REPORT and PROXY MATERIALS. Is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. Pacific Biosciences of California, Inc. Fourth Quarter 2017 Earnings Conference Call. Feb 1, 2018 1:30 PM PST. 36th Annual JP Morgan Healthcare Conference. Jan 8 11, 2018. Westin St. Francis. Piper Jaffray 29th Annual Healthcare Confernce. Nov 28 29, 2017.
Pacific Web Works, Inc.
If you are not taken to our investor section after 10 seconds click here.
SOCIAL ENGAGEMENT